NDC 63020-536

Iclusig

Ponatinib Hydrochloride

Iclusig is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Ponatinib Hydrochloride.

Product ID63020-536_568f48fb-4038-429a-8d32-0e6a8b833638
NDC63020-536
Product TypeHuman Prescription Drug
Proprietary NameIclusig
Generic NamePonatinib Hydrochloride
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-01-11
Marketing CategoryNDA / NDA
Application NumberNDA203469
Labeler NameTakeda Pharmaceuticals America, Inc.
Substance NamePONATINIB HYDROCHLORIDE
Active Ingredient Strength10 mg/1
Pharm ClassesKinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63020-536-30

30 TABLET, FILM COATED in 1 BOTTLE (63020-536-30)
Marketing Start Date2021-01-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Iclusig" or generic name "Ponatinib Hydrochloride"

NDCBrand NameGeneric Name
63020-533Iclusigponatinib hydrochloride
63020-534Iclusigponatinib hydrochloride
63020-535Iclusigponatinib hydrochloride
63020-536Iclusigponatinib hydrochloride
76189-533Iclusigponatinib hydrochloride
76189-534Iclusigponatinib hydrochloride
76189-535Iclusigponatinib hydrochloride

Trademark Results [Iclusig]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ICLUSIG
ICLUSIG
85254659 4324899 Live/Registered
ARIAD Pharmaceuticals, Inc.
2011-03-01
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.